Noha E. Farag

421 total citations
14 papers, 295 citations indexed

About

Noha E. Farag is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Noha E. Farag has authored 14 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Pharmacology. Recurrent topics in Noha E. Farag's work include Adipose Tissue and Metabolism (2 papers), Ion channel regulation and function (2 papers) and Cardiac electrophysiology and arrhythmias (2 papers). Noha E. Farag is often cited by papers focused on Adipose Tissue and Metabolism (2 papers), Ion channel regulation and function (2 papers) and Cardiac electrophysiology and arrhythmias (2 papers). Noha E. Farag collaborates with scholars based in Egypt, Saudi Arabia and United States. Noha E. Farag's co-authors include Sawsan A. Zaitone, Shymaa E. Bilasy, Manal S. Fawzy, Dina M. Khodeer, Yasser M. Moustafa, Lamiaa N. Hammad, Bassant M. Barakat, Eman Z. Abdelaziz‎, Mohamed Ahmed Eladl and Hala M.F. Mohammad and has published in prestigious journals such as Biomedicine & Pharmacotherapy, Nanomaterials and Frontiers in Endocrinology.

In The Last Decade

Noha E. Farag

14 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noha E. Farag Egypt 10 79 64 43 42 34 14 295
Qun Zheng China 13 241 3.1× 67 1.0× 45 1.0× 25 0.6× 32 0.9× 19 440
Zsolt Sárszegi Hungary 9 142 1.8× 88 1.4× 27 0.6× 31 0.7× 26 0.8× 15 353
Minakshi Rana India 11 116 1.5× 25 0.4× 30 0.7× 28 0.7× 64 1.9× 17 331
Dalia Zaafar Egypt 14 106 1.3× 24 0.4× 36 0.8× 30 0.7× 11 0.3× 33 357
Sanjeev Kalra India 12 128 1.6× 40 0.6× 65 1.5× 21 0.5× 33 1.0× 18 371
Dániel Priksz Hungary 14 132 1.7× 104 1.6× 28 0.7× 46 1.1× 27 0.8× 42 408
Wedad S. Sarawi Saudi Arabia 11 122 1.5× 23 0.4× 18 0.4× 15 0.4× 32 0.9× 41 334
Sung Cil Lim South Korea 14 120 1.5× 38 0.6× 67 1.6× 12 0.3× 22 0.6× 38 360
Andrej Barta Slovakia 14 82 1.0× 106 1.7× 24 0.6× 50 1.2× 22 0.6× 29 424

Countries citing papers authored by Noha E. Farag

Since Specialization
Citations

This map shows the geographic impact of Noha E. Farag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noha E. Farag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noha E. Farag more than expected).

Fields of papers citing papers by Noha E. Farag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noha E. Farag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noha E. Farag. The network helps show where Noha E. Farag may publish in the future.

Co-authorship network of co-authors of Noha E. Farag

This figure shows the co-authorship network connecting the top 25 collaborators of Noha E. Farag. A scholar is included among the top collaborators of Noha E. Farag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noha E. Farag. Noha E. Farag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Farag, Noha E., et al.. (2025). Efficacy, safety and mechanistic insights of pentoxifylline in major depressive disorder: a systematic review and meta-analysis of randomized controlled trials. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(7). 8125–8138. 2 indexed citations
2.
El‐Sayed, Mohamed H., Mohamed Ahmed Eladl, Noha E. Farag, et al.. (2023). Betanin improves motor function and alleviates experimental Parkinsonism via downregulation of TLR4/MyD88/NF-κB pathway: Molecular docking and biological investigations. Biomedicine & Pharmacotherapy. 164. 114917–114917. 20 indexed citations
3.
Mohammad, Hala M.F., et al.. (2022). Metformin suppresses LRG1 and TGFβ1/ALK1-induced angiogenesis and protects against ultrastructural changes in rat diabetic nephropathy. Biomedicine & Pharmacotherapy. 158. 114128–114128. 23 indexed citations
4.
Alshaman, Reem, Abdullah Alattar, Ahmed R. Gardouh, et al.. (2022). Formulation and Characterization of Doxycycline-Loaded Polymeric Nanoparticles for Testing Antitumor/Antiangiogenic Action in Experimental Colon Cancer in Mice. Nanomaterials. 12(5). 857–857. 16 indexed citations
5.
Farag, Noha E., Mohamed K. El-Kherbetawy, Hussein Ismail, et al.. (2021). Differential Effect of Three Macrolide Antibiotics on Cardiac Pathology and Electrophysiology in a Myocardial Infarction Rat Model: Influence on Sodium Nav1.5 Channel Expression. Pharmaceuticals. 14(7). 597–597. 7 indexed citations
6.
El-Sherbeeny, Nagla A., et al.. (2020). Carbamazepine conquers spinal GAP43 deficiency and sciatic Nav1.5 upregulation in diabetic mice: novel mechanisms in alleviating allodynia and hyperalgesia. Archives of Pharmacal Research. 43(7). 724–734. 5 indexed citations
7.
Atteia, Hebatallah Husseini, et al.. (2020). Evening Primrose Oil Ameliorates Hyperleptinemia and Reproductive Hormone Disturbances in Obese Female Rats: Impact on Estrus Cyclicity. Frontiers in Endocrinology. 10. 942–942. 13 indexed citations
8.
Khodeer, Dina M., et al.. (2019). Sitagliptin protects diabetic rats with acute myocardial infarction through induction of angiogenesis: role of IGF-1 and VEGF. Canadian Journal of Physiology and Pharmacology. 97(11). 1053–1063. 18 indexed citations
10.
Zaitone, Sawsan A., Bassant M. Barakat, Shymaa E. Bilasy, et al.. (2015). Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure. Naunyn-Schmiedeberg s Archives of Pharmacology. 388(6). 587–600. 47 indexed citations
11.
Farag, Noha E., et al.. (2015). Relation of insulin-like growth factor to skin ageing. Journal of the Egyptian Womenʼs Dermatologic Society. 12(3). 174–179. 1 indexed citations
12.
Khodeer, Dina M., Sawsan A. Zaitone, Noha E. Farag, & Yasser M. Moustafa. (2015). Cardioprotective effect of pioglitazone in diabetic and non-diabetic rats subjected to acute myocardial infarction involves suppression of AGE-RAGE axis and inhibition of apoptosis. Canadian Journal of Physiology and Pharmacology. 94(5). 463–476. 30 indexed citations
13.
Farag, Noha E., et al.. (2014). Cardioprotective effects of curcumin and nebivolol against doxorubicin-induced cardiac toxicity in rats. Human & Experimental Toxicology. 33(8). 800–813. 67 indexed citations
14.
Zaitone, Sawsan A., Lamiaa N. Hammad, & Noha E. Farag. (2013). Antioxidant potential of melatonin enhances the response to L-dopa in 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine-parkinsonian mice. Pharmacological Reports. 65(5). 1213–1226. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026